Даваа–Баасан 08:30–20:00 · Бямба 09:00–16:00
Now showing 1 - 10 of 13
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Clinical Immunology, the Fifth Edition
    (Mongolian National University of Medical Sciences, 2019-06-25) ; ;
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Challenges and Lessons from Novel Coronavirus Infection
    (Mongolian National University of Medical Sciences, 2020-04-01) ; ;
  • Some of the metrics are blocked by your 
    Item type:Publication,
    The Technological Study to Develop Granules from Plants Used in Traditional Mongolian Medicine
    (Mongolian National University of Medical Sciences, 2025-03-31) ; ; ; ;
    Objective: To develop a herbal preparation for respiratory ailments from plants used in Mongolian medicine. Method: TLC, HPLC, chemical and spectrophotometric analysis were used for the quality and quantitative determination of biologically active compounds in plant raw materials, extracts and granules. The total and internal absorption coefficients of the plant raw materials, tapped density and flowability of the granules were determined using the method of I.A. Muravyev and V.D. Ponomarev. The quality parameters of the granules (appearance, particle size, moisture content, dispersion) were determined by the Chinese pharmacopoeia methods. Results: The highest amount of extractive matters was determined when extracting 2 mm powdered roots of Glycyrrhiza uralensis Fisch.ex DC. using 0.25% ammonia (34.46±3.01), 2 mm powdered roots of Inula helenium L. with 50% ethanol (56.69±2.83), and 2 mm powdered fruits of Rosa acicularis Lindl. with 40% ethanol (32.15±1.62). The glycyrrhizic acid content in the root of Glycyrrhiza uralensis Fisch.ex DC. was measured at 3.51±1.73%. Similarly, the inulin content in the root of Inula helenium L. was found to be 5.56±0.003%, and the ascorbic acid content in the fruits of Rosa acicularis Lindl. was also identified as 1.91±0.1%. After determining the extractive matters, particle size, total and internal absorption coefficients, and the content of majn biologically active compounds in the plant materials, liquid extracts were obtained from the plant raw materials, and thick extracts were prepared from these liquid extracts. The main substances in the liquid and thick extracts were identified and quantified. The glycyrrhizic acid content was 1.04±0.01% in the liquid extract and 2.87±0.08% in the thick extract; the ascorbic acid content was 0.47 ± 0.06% in the liquid extract and 0.73 ±0.06% in the thick extract; and the inulin content was 4.72±0.002% in the liquid extract and 15.07±0.002% in the thick extract. Five different models of granules were prepared from thick extracts using the wet granulation method. Model 1 granules were excluded from the study due to their irregular texture, clamminess, and inability to be sieved. The quality and technological parameters of the granule F2 model were superior to those of the other models (P<0.001). Granule model F2 contains 0.092±0.002% glycyrrhizic acid, 2.153±0.049% inulin, and 0.27±0.03% ascorbic acid. The prepared granules met the criteria for the microbiological test. Conclusion: It is suitable to extract the roots of Glycyrrhiza uralensis Fisch.ex DC., the root of Inula helenium L., and the fruits of Rosa acicularis Lindl. by powdering them into 2 mm particle sizes. Of the five models of granules prepared by wet granulation from plant extracts, model 2 was superior to the others in terms of technological and quality parameters. Sucrose was not suitable for granulation as an excipient.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Sex-adjusted approach to baseline variables demonstrated some improved predictive capabilities for disease severity and survival in patients with Coronavirus Disease 19
    (Elsevier BV, 2022) ; ; ;
    Dambaa, Naranzul
    ;
    Boldoo, Tsolmon
    INTRODUCTION: The study was focused on comparing crude and sex-adjusted hazard ratio calculated by the baseline variables which may have contributed to the severity of the disease course and fatal outcomes in Coronavirus Disease-19 (COVID-19) patients. METHOD: The study enrolled 150 eligible adult patients with confirmed SARS-CoV-2 infection. There were 61 (40.7%) male patients, and 89 (59.3%) female patients. Baseline information of patients was collected from patient medical records and surveys that the patients had completed on admission to the hospital. RESULTS: Considerable number of baseline variables stratified according to disease severity and outcomes showed different optimal cut-points (OCP) in men and women. Sex-adjusted baseline data categories such as age; BMI; systolic and diastolic blood pressure; peripheral RBC and platelet counts; haematocrit; percentage of neutrophils, lymphocytes, monocytes, and their ratio; percentage of eosinophils; titre of plasma IL-6, IL-8, IL-10, and IL-17; and CXCL10; and ratio of pro- and anti-inflammatory cytokines demonstrated significant impacts on the development of the severe stage and fatal outcomes by the mean hazard ratio in the Kaplan-Meier and Cox regression models. CONCLUSION: This study confirmed some improved predictive capabilities of the sex-adjusted approach in the analysis of the baseline predictive variables for severity and outcome of the COVID-19.
    Scopus© Citations 1
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Reveromycin A, a novel acid-seeking agent, ameliorates bone destruction and tumor growth in multiple myeloma
    (2021-04)
    Watanabe, Keiichiro
    ;
    ;
    Tenshin, Hirofumi
    ;
    Cui, Qu
    ;
    Teramachi, Jumpei
    Scopus© Citations 7
  • Some of the metrics are blocked by your 
    Item type:Publication,
    OX40-heparan sulfate binding facilitates CAR T cell penetration into solid tumors in mice
    (American Association for the Advancement of Science (AAAS), 2025-06)
    Zhang, Huihui
    ;
    Zhong, Runbo
    ;
    Wang, Wanting
    ;
    Huang, Yue
    ;
    Li, Fanlin
    Although chimeric antigen receptor (CAR)-modified T cells have shown great success in treating B cell malignancies, they have demonstrated only limited efficacy against solid tumors. Here, we designed a CAR by integrating an antigen-independent OX40 that showed superior antitumor efficacy against multiple solid tumors. We unexpectedly found, through a CRISPR-Cas9-based whole-genome screen, that heparan sulfate is a ligand for OX40. We found that heparan sulfate can directly bind OX40 at the biochemical and cellular levels and that the interaction of heparan sulfate and OX40 activated the AKT, MAPK, and NF-κB signaling pathways. Functionally, the heparan sulfate-OX40 interaction enhanced cell adhesion and CAR T cell functional binding avidity to tumor cells. In vivo, OX40-expressing CAR T cells exhibited increased solid tumor infiltration and persistence dependent on the OX40-heparan sulfate interaction. Our findings provide insights into a glycan-costimulation interaction that is capable of regulating T cell immunity and has potential application in CAR T cell optimization.
    Scopus© Citations 13
  • Some of the metrics are blocked by your 
    Item type:Publication,
    The Roles of ROS Generation in RANKL-Induced Osteoclastogenesis: Suppressive Effects of Febuxostat
    (2020-04)
    Ashtar, Mohannad
    ;
    Tenshin, Hirofumi
    ;
    Teramachi, Jumpei
    ;
    ;
    Hiasa, Masahiro
    Receptor activator of NF-κB ligand (RANKL), a critical mediator of osteoclastogenesis, is upregulated in multiple myeloma (MM). The xanthine oxidase inhibitor febuxostat, clinically used for prevention of tumor lysis syndrome, has been demonstrated to effectively inhibit not only the generation of uric acid but also the formation of reactive oxygen species (ROS). ROS has been demonstrated to mediate RANKL-mediated osteoclastogenesis. In the present study, we therefore explored the role of cancer-treatment-induced ROS in RANKL-mediated osteoclastogenesis and the suppressive effects of febuxostat on ROS generation and osteoclastogenesis. RANKL dose-dependently induced ROS production in RAW264.7 preosteoclastic cells; however, febuxostat inhibited the RANKL-induced ROS production and osteoclast (OC) formation. Interestingly, doxorubicin (Dox) further enhanced RANKL-induced osteoclastogenesis through upregulation of ROS production, which was mostly abolished by addition of febuxostat. Febuxostat also inhibited osteoclastogenesis enhanced in cocultures of bone marrow cells with MM cells. Importantly, febuxostat rather suppressed MM cell viability and did not compromise Dox's anti-MM activity. In addition, febuxostat was able to alleviate pathological osteoclastic activity and bone loss in ovariectomized mice. Collectively, these results suggest that excessive ROS production by aberrant RANKL overexpression and/or anticancer treatment disadvantageously impacts bone, and that febuxostat can prevent the ROS-mediated osteoclastic bone damage.
    Scopus© Citations 43
  • Some of the metrics are blocked by your 
    Item type:Publication,
    SARS-CoV-2 seroprevalence in Mongolia: Results from a national population survey
    (Elsevier BV, 2021-12) ; ;
    Le, Linh-Vi
    ;
    ;
    BACKGROUND: With the global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in early 2020, Mongolia implemented rapid emergency measures and did not report local transmission until November 2020. We conducted a national seroprevalence survey to monitor the burden of SARS-CoV-2 in Mongolia in the months surrounding the first local transmission. METHODS: During October-December 2020, participants were randomly selected using age stratification and invited for interviews and blood samples at local primary health centres. We screened for total SARS-CoV-2 antibodies, followed by two-step quantitative SARS-CoV-2 IgG serology tests for positive samples. Weighted and test-adjusted seroprevalences were estimated. We used chi-square, Fisher's exact and other tests to identify variables associated with seropositivity. FINDINGS: A total of 5000 subjects were enrolled. We detected SARS-CoV-2 IgG antibodies in 72 samples. Crude seroprevalence of SARS-CoV-2 antibodies was 1·44% (95%CI,1·21-1·67). Population weighted and test-adjusted seroprevalences were 1·36% (95%CI,1·11-1·63) and 1·45% (95%CI,1·11-1·63), respectively. Age, sex, geographical, and occupational factors were not associated with seropositivity (p>0·05). Symptoms and signs within past 3 months and seropositivity were not associated at the time of the survey (p>0·05). INTERPRETATION: SARS-CoV-2 seroprevalence in Mongolia was low in the first year of the pandemic potentially due to strong public health measures, including border restrictions, educational facilities closure, earlier adoption of mask-wearing and others. Our findings suggest large-scale community transmission could not have occurred up to November 2020 in Mongolia. Additional serosurveys are needed to monitor the local pandemic dynamic and estimate how far from herd immunity Mongolia will be following-up with vaccination programme in 2021 and 2022. FUNDING: World Health Organisation, WHO UNITY Studies initiative, with funding by the COVID-19 Solidarity Response Fund and the German Federal Ministry of Health (BMG) COVID-19 Research and development. TRANSLATION: Cyrillic and Traditional Mongolian translation of abstract is available on appendix section.
    Scopus© Citations 14
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Scopus© Citations 4
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Mutual amplification of sensory nerve outgrowth and tumor progression in myeloma
    (2026-08)
    Nakagawa, Motosumi
    ;
    Hiasa, Masahiro
    ;
    Teramachi, Jumpei
    ;
    Harada, Takeshi
    ;
    Oda, Asuka